Afrezza Recent News
Diabetic Investor On MannKind: 'There's A Reason Why So Many People Are Short This Stock'
Calls Of Note: The Research Moving Stocks Today
MannKind Corporation Sinks: CFO Says 'We're Not There Yet' With Afrezza
Jefferies: MannKind's Consumer Ads For Afrezza May Increase Awareness
MannKind 'Facing Low Profitability And Delayed Profits' As Afrezza Ramp Fizzles, Goldman Says
Piper Jaffray Dishes On MannKind's Afrezza Data
MannKind Disappoints Again With Afrezza Sales
What's Afrezza's Ultimate Potential For MannKind?
Analyst: MannKind Afrezza Estimates Are Being Changed 'Based On Physician Feedback'
Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments
Markets Little Changed As The Quarter Comes To An End
One Small Step For Afrezza, One Huge Step For MannKind?
Market Wrap For April 7: Bears In Complete Control As Markets Get Hammered Yet Again
Market Wrap For April 2: Markets On Four-Day Winning Streak
Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy
Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains
MannKind Corporation Down 23.2% After Hitting 52-Week Low (MNKD)
MannKind Corp Climbs 8.6% (MNKD)